Literature DB >> 34219930

Seronegative necrotizing autoimmune myopathy with favorable response to intravenous immunoglobulin.

Rebecca Liu1, Andrew Z Fenves2, Samantha N Champion3, Jonathan Dau4.   

Abstract

We describe a 68-year-old man who presented with progressive weakness in proximal muscles of all four limbs and was found to have autoantibody-negative necrotizing autoimmune myopathy (NAM). His myopathy was refractory to corticosteroids and methotrexate, but subsequently demonstrated successful response to intravenous immunoglobulin (IVIG). The patient also received rituximab, but the timing of his recovery favored IVIG as the more important factor in terms of efficacy. Treatment guidelines for seronegative necrotizing myopathies are lacking. This case suggests a potential efficacious treatment option for the seronegative subset of NAM.
Copyright © 2021 Baylor University Medical Center.

Entities:  

Keywords:  HMGCR; SRP; immune-mediated necrotizing myopathy; myositis; necrotizing autoimmune myopathy

Year:  2021        PMID: 34219930      PMCID: PMC8224219          DOI: 10.1080/08998280.2021.1885091

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  10 in total

Review 1.  Necrotizing autoimmune myopathy.

Authors:  Christina Liang; Merrilee Needham
Journal:  Curr Opin Rheumatol       Date:  2011-11       Impact factor: 5.006

Review 2.  Inflammatory muscle diseases.

Authors:  Marinos C Dalakas
Journal:  N Engl J Med       Date:  2015-04-30       Impact factor: 91.245

3.  Intravenous Immune Globulin for Statin-Triggered Autoimmune Myopathy.

Authors:  Andrew L Mammen; Eleni Tiniakou
Journal:  N Engl J Med       Date:  2015-10-22       Impact factor: 91.245

Review 4.  Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.

Authors:  Floranne C Ernste; Ann M Reed
Journal:  Mayo Clin Proc       Date:  2013-01       Impact factor: 7.616

Review 5.  Diagnosis and Management of Immune-Mediated Myopathies.

Authors:  Margherita Milone
Journal:  Mayo Clin Proc       Date:  2017-05       Impact factor: 7.616

6.  Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy.

Authors:  Charles D Kassardjian; Vanda A Lennon; Nora B Alfugham; Michael Mahler; Margherita Milone
Journal:  JAMA Neurol       Date:  2015-09       Impact factor: 18.302

Review 7.  Paraneoplastic necrotizing myopathy: clinical and pathological features.

Authors:  M I Levin; T Mozaffar; M T Al-Lozi; A Pestronk
Journal:  Neurology       Date:  1998-03       Impact factor: 9.910

Review 8.  Immune-mediated necrotizing myopathy associated with statins: history and recent developments.

Authors:  Eleni Tiniakou; Lisa Christopher-Stine
Journal:  Curr Opin Rheumatol       Date:  2017-11       Impact factor: 5.006

Review 9.  Autoimmune Myopathies: Updates on Evaluation and Treatment.

Authors:  Emer R McGrath; Christopher T Doughty; Anthony A Amato
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

10.  Autoantibody-Negative Immune-Mediated Necrotizing Myopathy Responds to Early and Aggressive Treatment: A Case Report.

Authors:  Dario A Marotta; Adena Zadourian; Maxwell J Jabaay; Ali Kesserwani; Hassan Kesserwani
Journal:  Cureus       Date:  2020-04-25
  10 in total
  1 in total

1.  Immune-Mediated Myopathy in a Patient Presenting for Melanoma Resection and Sentinel Lymph Node Biopsy.

Authors:  Allan R Escher; Jamie P Hoffman; Sarah Alfieri; Bruno Bordoni; Raymond M Evans
Journal:  Cureus       Date:  2022-03-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.